⌘K
Loading ticker…
As of 2026-08-24, Prime Medicine, Inc. Common Stock (PRME) has a 3-month relative strength percentile of 66 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.6%, relative volume 0.83×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
PRME is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -1.2% / -8.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
PRME is held by 17 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $5M.
Held by 44 ETFs · $71M across latest filings · largest weight 1.41% (ARKG).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $2M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VHTVanguard Health Care ETF | 0.01% | $956K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $319K | — |
| VTWV | 0.02% | $280K | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| GNOM | 0.34% | $189K | −0.02 pp |
| GINN | 0.05% | $99K | — |
| IBBQ | 0.05% | $34K | −0.01 pp |
| VTHRVanguard Russell 3000 ETF | 0.00% | $32K | — |
| OMFS | 0.01% | $29K | new |
Showing 10 of 17 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PRME Jan avg: -7.01% median: -4.75% win: 25% σ: 15.79% n: 4 2022-10-21 → 2026-07-31 | PRME Feb avg: 10.16% median: 7.36% win: 50% σ: 22.15% n: 4 2022-10-21 → 2026-07-31 | PRME Mar avg: -22.43% median: -22.85% win: 0% σ: 2.99% n: 4 2022-10-21 → 2026-07-31 | PRME Apr avg: -7.24% median: -5.60% win: 50% σ: 18.17% n: 4 2022-10-21 → 2026-07-31 | PRME May avg: -0.08% median: -0.11% win: 50% σ: 25.92% n: 4 2022-10-21 → 2026-07-31 | PRME Jun avg: 24.84% median: 5.36% win: 75% σ: 57.65% n: 4 2022-10-21 → 2026-07-31 | PRME Jul avg: 10.64% median: 6.00% win: 75% σ: 30.10% n: 4 2022-10-21 → 2026-07-31 | PRME Aug avg: -16.41% median: -13.37% win: 0% σ: 6.35% n: 3 2022-10-21 → 2026-07-31 (current) | PRME Sep avg: 11.15% median: -9.58% win: 33% σ: 52.63% n: 3 2022-10-21 → 2026-07-31 | PRME Oct avg: -5.02% median: -5.29% win: 50% σ: 22.67% n: 4 2022-10-21 → 2026-07-31 | PRME Nov avg: -8.67% median: -11.93% win: 25% σ: 14.84% n: 4 2022-10-21 → 2026-07-31 | PRME Dec avg: 2.43% median: -0.54% win: 50% σ: 15.68% n: 4 2022-10-21 → 2026-07-31 |